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A B S T R A C T
Huntington's disease (HD) is caused by CAG repeat expansion within the HTT gene, with the dysfunction and
eventual loss of striatal medium spiny neurons a notable feature. Since medium spiny neurons receive high
amounts of synaptic input, we hypothesised that this vulnerability originates from an inability to sustain pre-
synaptic performance during intense neuronal activity. To test this hypothesis, primary cultures of either hip-
pocampal or striatal neurons were prepared from either wild-type mice or a knock-in HD mouse model which
contains 140 poly-glutamine repeats in the huntingtin protein (httQ140/Q140). We identified a striatum-specific
defect in synaptic vesicle (SV) endocytosis in httQ140/Q140 neurons that was only revealed during high frequency
stimulation. This dysfunction was also present in neurons that were heterozygous for the mutant HTT allele.
Depletion of endogenous huntingtin using hydrophobically-modified siRNA recapitulated this activity-depen-
dent defect in wild-type neurons, whereas depletion of mutant huntingtin did not rescue the effect in httQ140/Q140
neurons. Importantly, this SV endocytosis defect was corrected by overexpression of wild-type huntingtin in
homozygous httQ140/Q140 neurons. Therefore, we have identified an activity-dependent and striatum-specific
signature of presynaptic dysfunction in neurons derived from pre-symptomatic HD mice, which is due to loss of
wild-type huntingtin function. This presynaptic defect may render this specific neuronal subtype unable to
operate efficiently during high frequency activity patterns, potentially resulting in dysfunctional neuro-
transmission, synapse failure and ultimately degeneration.
1. Introduction
Neurotransmitter release is a tightly controlled event, relying on the
synchronous coupling of activity-dependent calcium influx to synaptic
vesicle (SV) fusion (Sudhof, 2012). This process can be difficult to
sustain however, since SVs are highly limited within a typical small
central nerve terminal (Schikorski and Stevens, 2001; Wilhelm et al.,
2014). To maintain the fidelity of neurotransmission, SVs are recycled
locally within the presynapse, with both SV cargo and membrane re-
formed into fusion-competent SV by endocytosis (Cousin, 2017; Saheki
and De Camilli, 2012). When SV endocytosis is perturbed,
neurotransmission is disrupted (Chen et al., 2003; Koh et al., 2004; Koo
et al., 2015; Shupliakov et al., 1997).
Huntington's Disease (HD) is a monogenic disorder caused by a
variable CAG expansion in exon 1 of the HTT gene, resulting in the
expressed huntingtin protein (htt) containing an extended poly-
glutamine tract. The disease is characterized by chorea followed by
hypokinesis, thought to result from a specific degeneration of medium
spiny neurons (MSNs) in the striatum (Vonsattel et al., 1985). However,
a molecular explanation for the loss of this specific neuronal subtype is
currently undetermined.
An emerging theme in a number of degenerative conditions is the
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premise that early presynaptic dysfunction plays a contributory role
towards later pathological outcomes (Waites and Garner, 2011). In this
regard, striatal MSNs receive a high level of excitatory synaptic input to
maintain them in their “up” state (Milnerwood and Raymond, 2010;
Wolf et al., 2005). This suggests that the polyglutamine expansion in
mutant htt (mhtt) may result in an intrinsic inability of MSNs to sustain
neurotransmitter release during such input, rendering them unable to
maintain the fidelity of neurotransmission with downstream synaptic
partners. Consistent with this, dysfunctional striatal transmission with
its target areas has been observed in electrophysiological studies in
animal models (Barry et al., 2018) and terminal loss (presumably pre-
ceded by dysfunction) has been recorded in human neuropathological
studies (Albin et al., 1992; Reiner et al., 1988).
Wild-type htt is enriched at central nerve terminals (DiFiglia
et al., 1995; Yao et al., 2014), suggesting it performs a role in pre-
synaptic function that may be disrupted on poly-glutamine expan-
sion in HD. We tested the hypothesis that poly-glutamine expansion
of mhtt results in the intrinsic dysfunction of specific neuronal sub-
types that would only be revealed by elevated neuronal activity. To
achieve this, we examined how high frequency input impacted on
presynaptic function in primary neuronal cultures derived from the
httQ140/Q140 knock-in mouse (Menalled et al., 2003). We discovered
an activity-dependent defect in SV endocytosis that was specific to
striatal neurons. Importantly, this defect was a consequence of loss of
wild-type htt function and was observed in heterozygous neurons,
providing potential disease relevance. The activity-dependent nature
of this SV endocytosis defect suggests that the intrinsic dysfunction
of striatal HD neurons may result in an inability to sustain neuro-
transmission during high frequency input, resulting in synaptic
failure and ultimately their degeneration.
2. Materials and methods
2.1. Materials
Synaptophysin-pHluorin (Syp-pH) was provided by Prof. L.
Lagnado (University of Sussex). The htt expression plasmid (human
Htt-Q22-pcDNA3.1) provided by Cure Huntington's Disease Initiative
(CHDI) via the Coriell Institute for Medical Research (Camden, NJ).
HttQ140/Q140 knockin mice were provided by CHDI via The Jackson
Laboratory. The following antibodies were used: mouse anti-α-
adaptin (for immunoprecipitation, Thermo Scientific MA1–064),
mouse anti-Htt (1:8000 for WB; Merck MAB2166) and mouse anti-β-
actin (1:250000 for WB; Sigma-Aldrich A3854). Rabbit anti-Htt
(1:250; Abcam 109115), chicken anti-GFP (1:2000; Abcam 13970)
and Alexa-conjugated secondary antibodies (1:500) were purchased
from Life Technologies (Paisley, UK). Secondary antibodies for WB
(IRDye 800CW anti-mouse; LI-COR 927–32210, 1:10000) and
Odyssey blocking buffer (927–4000) were purchased from LI-COR
Biosciences (Cambridge, UK). Neurobasal media, B-27 supplement,
penicillin/streptomycin, Minimal Essential Medium, Dulbecco's
Minimal Essential Medium: Nutrient Mixture F12, Lipofectamine
2000, phosphate buffered salts, were obtained from Life
Technologies. Papain was from Lorne laboratories (Reading, UK).
APV and CNQX were from Abcam (Cambridge, UK). All other re-
agents were obtained from Sigma-Aldrich (Poole, UK).
2.2. Oligonucleotide synthesis, deprotection and purification
Hydrophobic modification of siRNA enables efficient inter-
nalization by primary neurons without requirement for standard
transfection methods (Alterman et al., 2015). HsiRNA against htt
(HTT10150) and NTC hsiRNA were based on a previously identified
HTT functional targeting site (Alterman et al., 2015). The
compounds were asymmetric, composed of a 15-nucleotide long
duplex region with a single-stranded 3′ extension on the guide
strand. All bases were modified using alternating 2′-O-methyl /2′-
fluoro modification pattern with additional 14 phosphorothioates
incorporated (Table 1). The 3′ end of the passenger strand was
conjugated to a hydrophobic teg-Chol (tetraethylene glycol choles-
terol).
Oligonucleotides were synthesized on an OligoPilot100 Synthesizer.
Both sense and antisense strands were cleaved and deprotected using
40% aq.methylamine at 65 °C for 15min. The oligonucleotide solutions
were then cooled in a freezer and dried under vacuum in a Speedvac.
The resulting pellets were suspended in water. The final purification of
oligonucleotides was performed on an Agilent Prostar System (Agilent,
Santa Clara, CA) equipped with a Hamilton HxSil C18 column
(150× 21.2). The pure oligonucleotides were collected, desalted by
size-exclusion chromatography using a Sephadex G25 and lyophilized.
The identity of oligonucleotides was established by LC-MS analysis on
an Agilent 6530 accuratemass Q-TOF LC/MS (Agilent technologies,
Santa Clara, CA). The purified strands were duplexed and duplex for-
mation and purity were confirmed by gel electrophoresis.
2.3. Mouse colony maintenance and management
All animal work was performed in accordance with the UK Animal
(Scientific Procedures) Act 1986, under Project and Personal License
authority and was approved by the Animal Welfare and Ethical Review
Body at the University of Edinburgh. Specifically, all animals were
killed by schedule 1 procedures in accordance with UK Home Office
Guidelines. In-house colonies of either wild-type C57Bl/6J mice or
httQ140/Q140 knockin mice (which express a chimeric mouse/human
exon 1 inserted into the murine htt gene containing a 140 CAG ex-
pansion (Menalled et al., 2003)) on a C57Bl/6J background were
maintained as homozygotes. For specific experiments using hetero-
zygotes, these mice were crossed to obtain httQ140/+ offspring. Gene
sequencing to confirm CAG repeat length in httQ140/Q140 mice was
performed by Laragen (Culver City, US).
2.4. Primary neuronal culture
Primary cultures of striatal neurons were prepared, since selec-
tive loss of striatal MSNs is a key feature of HD (Milnerwood and
Raymond, 2010). Hippocampal neurons were prepared as a control
(Zhang et al., 2015). Either dissociated primary hippocampal- or
striatal-enriched cultures were generated from both male and female
E16–18 mouse embryos. Dissected tissue was digested in papain
(0.3 U / ml) supplemented phosphate buffered saline (PBS) at 37 °C
for 20 min. Papain was then removed and replaced with Dulbecco's
Modified Eagle Medium: Nutrient Mixture F-12 supplemented with
10% w/v foetal bovine serum and triturated to obtain a single-cell
suspension. The suspension was centrifuged for 5 min at 347g. The
supernatant was discarded and the pellet resuspended in Neurobasal
medium supplemented with 2% B-27 supplement, 0.5 mM L-gluta-
mine, and 1% v/v penicillin/streptomycin. Hippocampal and striatal
neurons were plated at a density of 4× 104 and 6.5× 104 cells/
coverslip respectively. Cells were plated onto a 50 μl laminin spot in
the centre of a 25 mm coverslip pre-coated with poly-D-lysine in boric
acid (100 mM, pH 8.5) within a 6-well plate. After 1 h, wells were
flooded in the same Neurobasal media as above, and media was
supplemented after 72 h with 1 μM cytosine β-d-arabinofuranoside to
inhibit glial proliferation. In htt knockdown experiments, 0.5 μM of
either hsiRNA or NTC was added to culture media after 7 days in
vitro (DIV). All other transfections were performed after 7 or 8 DIV
using 0.6–1.0 μg of DNA per plasmid and 2 μl of lipofectamine 2000
per well. Imaging experiments were performed at 13 to 15 DIV.
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2.5. Imaging and analysis of pHluorin reporters
SV recycling was visualised using syp-pH. Syp-pH has a pH-sensitive
GFP moiety (pHluorin) fused to an intraluminal loop of the SV protein
synaptophysin (Granseth et al., 2006). The fluorescence of syp-pH is
quenched by the acidic SV interior; however, during SV exocytosis its
fluorescence is unquenched on encountering the neutral pH of the ex-
tracellular medium. Syp-pH is then re-quenched during endocytosis and
subsequent SV acidification.
Coverslips containing primary cultures were mounted in a
Warner imaging chamber (RC-21BRFS) embedded with parallel
platinum wires (6 mm apart). Cultures were subjected to continuous
perfusion in imaging buffer containing (in mM): 119 NaCl, 2.5 KCl, 2
CaCl2, 2 MgCl2, 25 HEPES, 30 glucose, 0.01 CNQX and 0.05 AP5,
pH 7.4. Imaging was performed on a Zeiss Axio Observer D1 inverted
epifluorescence microscope (Zeiss Ltd. Germany) using a x40 1.3 NA
oil immersion objective at room temperature unless otherwise in-
dicated. Images were acquired at 4 s intervals using a Hamamatsu
Orca-ER camera (Hamamatsu, Japan). Cultures were electrically
stimulated with specific trains of electrical field stimulation (either
300 pulses delivered at 10 Hz or 400 pulses delivered at 40 Hz; both
100 mA, 1 ms pulse width). At the end of the experiment, cultures
were perfused with alkaline imaging buffer (50 mM NH4Cl sub-
stituted for 50 mM NaCl) to reveal total pHluorin fluorescence.
Wavelength settings for syp-pHluorin were 480 nm excitation
and > 525 nm emission. Offline processing was performed using Fiji is
just ImageJ (FIJI) software (Schindelin et al., 2012). Regions of interest
(ROIs) of identical size were placed over axonal nerve terminals
(Fig. 1A-D) and the fluorescence intensity was monitored over time
using the Time Series Analyser V2 plugin. The change in activity-de-
pendent pHluorin fluorescence was calculated as ΔF/F0 using Microsoft
Excel. Traces were normalised to the peak during stimulation or to total
pHluorin fluorescence (by normalising to the peak response in the
presence of alkaline buffer). In all cases, n refers to the number of in-
dependent coverslips examined.
2.6. Immunofluorescence
Nerve terminal htt expression was assessed using immuno-
fluorescence. After 13–15 DIV, neurons were washed twice with PBS
(pH 7.4) and fixed for 15min at room temperature in PBS containing
4% paraformaldehyde. Cultures were incubated for 5min with PBS
containing 50mM ammonium chloride, followed by two sequential
5 min PBS washes. Cells were permeabilized by incubation in 0.1%
Triton X-100 in PBS for 10min, followed by three PBS washes, and
blocking for 1 h with 2% BSA in PBS. Primary and secondary antibodies
were each diluted in 1% BSA in PBS and incubated with cells for 1 h at
room temperature and washed with three sequential PBS washes before
and after secondary incubation. Images were acquired on a Zeiss Axio
Observer D1 microscope using 480 nm excitation and > 510 emission
to visualise Alexa-488, and 550 nm excitation and > 575 nm emission
to visualise Alexa-568. Expression levels of htt were determined by
using FIJI software to measure the mean fluorescence intensity of
neuronal cell bodies. The mean fluorescence of a transfected neuron cell
body was normalised to the average of the mean fluorescence of the
neighbouring untransfected neurons within the same field of view.
Experimental n represents data from independent coverslips.
2.7. Immunoprecipitation
Forebrain synaptosomes were prepared from either adult wild-
type or httQ140/Q140 mice by differential centrifugation as previously
described (Anggono et al., 2006). Synaptosomes were lysed in ice-
cold lysis buffer (1% Triton X-100, 150 mM NaCl, 25 mM Tris pH 7.4,
1 mM EDTA, 1 mM EGTA, 20 mg/ml leupeptin, 1 mM phe-
nylmethylsulfonyl fluoride and protease inhibitor mix) for 15 min
and then centrifuged for 5 min at 20,000 g. Supernatants from this
lysate were incubated with Protein G-coupled Sepharose beads and
5 μg of α-adaptin antibody with rotation overnight. Beads were wa-
shed with lysis buffer twice, with lysis buffer supplemented with
500 mM NaCl once, again with lysis buffer and finally with 20 mM
Tris (pH 7.4). Bound proteins were then eluted in SDS sample buffer
(67 mM SDS, 2 mM EGTA, 9.3% glycerol, 12% β-mercaptoethanol,
bromophenol blue, 67 mM Tris, pH 7.4), boiled for 5 min at 95 °C and
analysed by Western blotting. Experimental n represents data from 6
separate immunoprecipitations.
2.8. Western blotting
Western blotting was used to assess immunoprecipitations and htt
knockdown efficiency. Approximately 150,000 neurons were plated on
individual coverslips, which were lysed at 13–15 DIV directly in SDS
sample buffer. Samples were boiled for 5min at 95 °C and resolved
using SDS-PAGE (4–20% gel, Bio-Rad), and transferred to nitrocellulose
membrane using a Bio-Rad Mini Trans-Blot Cell transfer apparatus. The
membrane was incubated for 1 h in Odyssey blocking buffer before a
1 h incubation rotating at room temperature in blocking buffer con-
taining 0.1% tween-20 and primary antibody. Four 5min washes in
blocking buffer occurred before and after 1 h incubation with secondary
antibody. Protein bands were detected with an Odyssey scanner
(800 nm channel) and quantified using FIJI software. Experimental n
represents data from neuronal lysates derived from independent cov-
erslips.
2.9. Experimental design and statistical analysis
All statistical analysis was performed in Graph Pad Prism 6.0. A one-
way ANOVA with Tukey's post-test was used to compare more than two
groups. A two-tailed student's t-test was performed when two groups
were compared. The sample size (n) was taken to be either the number
of independent experiments or individual coverslips as indicated above.
All data are presented as mean values± standard error of the mean
Table 1
Modification of hsiRNA.
siRNA ID Accession number Strand Sequence
hsiRNANTC N/A Sense fU#mG#fA.mC.fA.mA.fAm.U.fA.mC.fG.mA.fU#mU#fA-TegChol
Antisense PmU#fA#mA.fU.mC.fG.mU.fA.mU.fU.mU.fG.mU#fC#mA#fA#mU#fC#mA#fU
hsiRNAHTT NM_002111 Sense fC#mA#fG.mU.fA.mA.fA.mG.fA.mG.fA.mU.fU#mA#fA-TegChol
Antisense PmU#fU#mA.fA.mU.fC.mU.fC.mU.fU.mU.fA.mC#fU#mG#fA#mU#fA#mU#fA
Chemical modifications are designated as follows. “.” – Phosphodiester bond, “#” – Phosphorothioate bond, “m” – 2’-O-Methyl, “f” – 2’-Fluoro, “P” – 5’ Phosphate,
“TegChol” –Tetraethylene glycol (teg)-Cholesterol.
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(SEM).
3. Results
3.1. Establishment of an experimental system to interrogate presynaptic
dysfunction in HD neurons
Dysfunctional synaptic transmission is one of the key events that
precipitate a number of neurodegenerative disorders, sometimes
termed synaptopathies (Brose et al., 2010; Waites and Garner, 2011),
with HD included within this definition (Li et al., 2003; Milnerwood
and Raymond, 2010; Rozas et al., 2010). In this study, we investigated
whether presynaptic function was altered before overt pathological or
motor symptoms of HD occurred, to determine whether this may con-
tribute to disease initiation.
SV recycling was monitored in primary cultures derived from either
wild-type mice or a preclinical model of HD, the httQ140/Q140 knock-in
mouse. This mouse expresses a chimeric mouse/human exon 1, con-
taining a CAG repeat of approximately 140, inserted into the murine
HTT gene, resulting in a large polyglutamine expansion in the expressed
htt protein (Menalled et al., 2003). Primary cultures of striatal neurons
were examined since a key feature of HD is the selective loss of striatal
MSNs (Milnerwood and Raymond, 2010). Hippocampal neurons were
examined in parallel as a control.
Presynaptic function was monitored using the genetically encoded
reporter syp-pH. Syp-pH reports the pH of its immediate environment
by virtue of a pH-sensitive GFP moiety (pHluorin) fused to an in-
traluminal loop of the SV protein synaptophysin (Granseth et al., 2006).
When syp-pH is present inside SVs, its fluorescence is quenched by the
acidic lumenal pH; however, on translocation to the plasma membrane
its fluorescence is unquenched due to the neutral pH of the extracellular
medium. Neuronal activity results in syp-pH dequenching due to SV
fusion (exocytosis), resulting in an increase in fluorescence (Fig. 1A,B).
After neuronal activity terminates, the syp-pH fluorescence signal is re-
quenched by SV acidification after its retrieval by SV endocytosis
(Fig. 1C). The kinetics of SV endocytosis can be estimated by mon-
itoring the rate of fluorescence decrease post-stimulation (Kavalali and
Jorgensen, 2014), since SV acidification is not rate limiting in this
Fig. 1. – Establishment of an experimental platform to
study the effect of htt loss and gain of function in wild-
type and httQ140/Q140 neurons. Primary cultures of
wild-type (WT) hippocampal neurons were trans-
fected with synaptophysin-pHluorin (syp-pH) 7 days
prior to fluorescence imaging. Cultures were chal-
lenged with a train of 300 electrical field stimuli
delivered at 10 Hz followed by a pulse of ammonium
chloride buffer (NH4Cl). (A-D) Representative
images showing the syp-pH response either before
(Rest, A), during (10 Hz, B) or after (Recovery, C) the
stimulus train. The syp-pH signal in response to
NH4Cl challenge is displayed in D. Arrows indicate
typical responsive puncta. Scale bar represents
10 μm. (E) Representative Western blot of htt levels
from neuronal lysates derived from either wild-type
(WT) or httQ140/Q140 (Q140) hippocampal cultures
after 7 days in the presence of 0.5 μM of htt hsiRNA
(KD) or non-targeting control (NTC). Lysates from
untransfected (UnTf) neurons are also displayed. A
representative actin blot from the same membrane is
displayed. (F) Bar graph displays the average extent
of htt or mhtt expression (normalised to actin
loading controls) ± SEM as a proportion of trans-
fected controls. Red points indicate WT NTC, maroon
points WT KD, dark blue points Q140 NTC and light
blue points Q140 KD (WT NTC n=6, WT KD n=8;
Q140 NTC n=3, Q140 KD n=3; one-way ANOVA
to WT NTC, ***= p < .001). (For interpretation of
the references to colour in this figure legend, the
reader is referred to the web version of this article.)
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Fig. 2. – SV endocytosis is unaffected in httQ140/Q140
neurons at low stimulation frequencies. Primary cul-
tures of either hippocampal (HPC) or striatal (STR)
neurons generated from either wild-type (WT) or
httQ140/Q140 (Q140) mice were transfected with sy-
naptophysin-pHluorin (syp-pH). In addition, cultures
were treated with 0.5 μM of htt hsiRNA (KD) or a
non-targeting control (NTC) for 7 days previously.
Cultures were challenged with a train of 300 elec-
trical field stimuli delivered at 10 Hz followed by a
pulse of ammonium chloride buffer (NH4Cl). (A,C)
Traces display the time course of the average fluor-
escent syp-pH response normalised to the peak of
stimulation (ΔF/F0 ± SEM) in all conditions for ei-
ther HPC (A) or STR (C). Red traces indicate WT
NTC, maroon traces WT KD, dark blue traces Q140
NTC and light blue traces Q140 KD. Bar indicates
period of stimulation. (B,D) Quantification of the
time constant (τ) for the syp-pH fluorescence
decrease± SEM (HPC WT n=5 NTC, n= 6 KD;
HPC Q140, n=5 NTC, n=5 KD: STR WT n=3
NTC, n=4 KD; STR Q140 n=6 NTC, n= 4 KD
independent experiments). One-way ANOVA all not
significant. (For interpretation of the references to
colour in this figure legend, the reader is referred to
the web version of this article.)
Fig. 3. – SV endocytosis is disrupted in striatal httQ140/
Q140 neurons specifically during high neuronal activity.
Primary cultures of either hippocampal (HPC) or
striatal (STR) neurons generated from either wild-
type (WT), httQ140/Q140 (Q140) or httQ140/+ (Het)
mice were transfected with synaptophysin-pHluorin
(syp-pH). In addition cultures were treated with
0.5 μM of htt hsiRNA (KD) or a non-targeting control
(NTC) where indicated for 7 days previously.
Cultures were challenged with a train of 400 elec-
trical field stimuli delivered at 40 Hz followed by a
pulse of ammonium chloride buffer. (A,C) Traces
display the time course of the average fluorescent
syp-pH response normalised to the peak of stimula-
tion (ΔF/F0 ± SEM) in all conditions for either HPC
(A) or STR (C). Red traces indicate WT NTC, maroon
traces WT KD, dark blue traces Q140 NTC, light blue
traces Q140 KD and orange traces Het. Bar indicates
period of stimulation. (B,D) Quantification of the
time constant (τ) for the syp-pH fluorescence
decrease± SEM (HPC WT n=7 NTC, n=5 KD;
HPC Q140, n= 5 NTC, n=6 KD: STR WT n=7
NTC, n=11 KD; STR Q140 n=4 NTC, n=5 KD;
STR Het n=8). One-way ANOVA against WT NTC,
**= p < .01; *= p < .05. (For interpretation of
the references to colour in this figure legend, the
reader is referred to the web version of this article.)
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process (Atluri and Ryan, 2006; Egashira et al., 2015; Granseth et al.,
2006).
To determine whether any observed phenotype in httQ140/Q140
neurons was due to a loss of wild-type htt function or a toxic gain of
mhtt function, we employed hydrophobically-modified siRNA
(hsiRNA) which was designed to deplete both wild-type htt and mhtt
(Alterman et al., 2015). The rationale for this approach was that a
phenotype originating from a toxic gain of mhtt function would be
corrected by depletion of mutant htt in httQ140/Q140 neurons. In
contrast, if a loss of htt function was responsible for any phenotype,
depletion of htt in wild-type cultures should mimic the phenotype of
httQ140/Q140 neurons.
We first confirmed the knockdown efficiency of both wild-type htt
and mhtt in their respective cultures. The targeting hsiRNA efficiently
and equally depleted both htt in wild-type neurons and mhtt in httQ140/
Q140 neurons to approximately 20% of untransfected controls
(Fig. 1E,F). In contrast, there was no depletion of either htt or mhtt
compared to transfected neurons in wild-type and httQ140/Q140 hippo-
campal neurons that were treated with a non-targeting control (NTC)
hsiRNA (Fig. 1E,F). Therefore, we established an experimental system
that will 1) identify dysfunction in SV recycling in HD neurons, and 2)
whether any observed dysfunction is a result of a loss of normal htt
function or a toxic gain of mhtt function.
3.2. SV recycling has no obligatory requirement for htt
We first determined whether SV endocytosis was altered during
low frequency (10 Hz, 30 s) stimulation in either wild-type or
httQ140/Q140 neurons that were treated with hsiRNA (either targeting
or NTC). Importantly, delivery of hsiRNA did not impact on pre-
synaptic function (Supplementary Fig. 1). When wild-type and
httQ140/Q140 neurons were compared, there was no genotype-de-
pendent difference in either the extent (estimated by the return of the
syp-pH signal to baseline, Fig. 2A,C) or kinetics (estimated by the
time constant [Tau, τ] of syp-pH fluorescence decay, Fig. 2B,D) of SV
endocytosis for either hippocampal or striatal neurons. Furthermore,
depletion of either htt from wild-type neurons or mhtt from httQ140/
Q140 neurons had no impact on either the extent or kinetics of SV
endocytosis for both hippocampal and striatal neurons (Fig. 2). There
was no effect of any manipulation on the peak syp-pH response, in-
dicating no effect on evoked SV fusion events (Supplementary Fig. 2).
These experiments indicate that SV endocytosis is unaffected during
low levels of neuronal activity in httQ140/Q140 neurons derived from
different brain regions. Importantly, it also reveals that htt is dis-
pensable for SV endocytosis during low frequency stimulation, since
its depletion in wild-type neurons has no impact on this parameter.
3.3. HttQ140/Q140 knockin neurons display a striatum-specific, activity-
dependent defect in SV endocytosis due to loss of wild-type htt function
Our initial hypothesis was that poly-glutamine expansion of mhtt
would result in the selective dysfunction of specific neuronal sub-
types that are challenged by elevated neuronal activity. This is par-
ticularly pertinent for striatal MSNs, which receive a high frequency
of input (Milnerwood and Raymond, 2010). Therefore, we next as-
sessed the impact of increasing the stimulation frequency to 40 Hz
(400 field stimuli) on SV endocytosis. When the evoked syp-pH re-
sponse was monitored in hippocampal cultures treated with NTC
hsiRNA, no genotype-dependent alterations in either the extent or
kinetics of SV endocytosis was observed (Fig. 3A,B). In contrast,
striatal httQ140/Q140 NTC hsiRNA-treated cultures displayed a
slowing in the kinetics of SV endocytosis after high frequency sti-
mulation when compared to wild-type NTC hsiRNA-treated controls
(Fig. 3C,D). The extent of SV endocytosis was unaffected in striatal
httQ140/Q140 neurons, since the syp-pH response did return to base-
line (Supplementary Fig. 3). This striatum-specific, activity-depen-
dent defect was also apparent when these experiments were per-
formed at physiological temperatures (Fig. 4). This is an important
control, since it has been proposed that the activation of different SV
endocytosis modes is temperature-dependent (Chanaday and
Kavalali, 2018; Delvendahl et al., 2016; Watanabe et al., 2014).
Thus, striatal neurons from httQ140/Q140 mice display a selective
defect in the kinetics of SV endocytosis that is only revealed during
elevated neuronal activity.
We next determined whether this activity-dependent, striatum-
specific dysfunction in SV endocytosis was due to either a loss of wild-
type htt function or a toxic gain of mhtt function. When htt was de-
pleted with hsiRNA in either wild-type or httQ140/Q140 hippocampal
neurons, no effect on SV endocytosis was observed after high frequency
stimulation, in agreement with the lack of genotype effect in these
neurons (Fig. 3A,B). However, when htt was depleted in wild-type
striatal neurons, a significant slowing in the kinetics of SV endocytosis
was observed, very similar to that observed in NTC-treated httQ140/Q140
striatal neurons (Fig. 3C,D). When mutant htt was depleted in httQ140/
Fig. 4. – SV endocytosis is disrupted in striatal httQ140/
Q140 neurons during high neuronal activity at physiolo-
gical temperatures. Primary cultures of striatal neu-
rons generated from either wild-type (WT) or
httQ140/Q140 (Q140) mice were transfected with sy-
naptophysin-pHluorin (syp-pH). Cultures were chal-
lenged with a train of 400 electrical field stimuli
delivered at 40 Hz. (A) Traces display the time
course of the average fluorescent syp-pH response
normalised to the peak of stimulation (ΔF/
F0 ± SEM). Red traces indicate WT and blue traces
indicate Q140. Bar indicates period of stimulation.
(B) Quantification of the time constant (τ) for the
syp-pH fluorescence decrease± SEM (WT n=3,
Q140 n=5). Students t-test * p= .025. (For inter-
pretation of the references to colour in this figure
legend, the reader is referred to the web version of
this article.)
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Q140 striatal neurons, no additional retardation in SV endocytosis ki-
netics was observed compared to either NTC-treated httQ140/Q140
striatal neurons or hsiRNA-treated wild-type striatal neurons (Fig. 3D).
The extent of SV endocytosis was unaffected, as evidenced by the return
to baseline of the syp-pH response (Supplementary Fig. 3). Thus, the
activity-dependent defect in SV endocytosis observed exclusively in
httQ140/Q140 striatal neurons, is due to a loss of wild-type htt function
and not a toxic gain of mhtt function.
To address the possibility that the observed slowing of SV en-
docytosis in either httQ140/Q140 striatal neurons or hsiRNA-treated wild-
type neuronal cultures was due to altered SV exocytosis, we examined
the evoked peak height as a proportion of the total SV pool. The total SV
pool is revealed by dequenching the syp-pH signal with an ammonium
chloride buffer after completion of the experiment (Fig. 1D). To confirm
that the evoked peak height was an accurate measure of SV exocytosis,
we applied the V-type ATPase antagonist bafilomycin A1. This proce-
dure arrests SV acidification after endocytosis, and therefore reveals the
total number of SVs that visit the plasma membrane during a stimulus
train, since endocytosis cannot be detected (Sankaranarayanan and
Ryan, 2001). There was no difference in the peak syp-pH response
between neurons treated with or without bafilomycin A1 during a
40 Hz train of stimuli (bafilomycin A1 minus 39.7 ± 3.4% of total SV
pool n=7; plus 34.9 ± 5.3%, n=3, students t-test p= .47, Fig. 5A).
This indicates that very few SVs are retrieved during this high fre-
quency stimulus train, in agreement with previous work (Kokotos et al.,
2018). When the syp-pH peak heights evoked by 40 Hz stimulation
trains were examined, no change was observed across any experimental
condition, genotype or neuronal subtype (Fig. 5B,C). Therefore, the
observed defect in endocytosis in striatal neurons in unlikely to be a
secondary consequence of altered exocytosis.
3.4. Wild-type htt expression corrects the activity-dependent SV endocytosis
defect in striatal httQ140/Q140 neurons
We have discovered that loss of wild-type htt function pre-
cipitates a defect in SV endocytosis that is only revealed during in-
tense neuronal activity in striatal httQ140/Q140 neurons. This suggests
that the introduction of wild-type htt into httQ140/Q140 neurons may
rescue presynaptic function. To determine this, we expressed wild-
type htt (with a polyglutamine tract of 22, Q22-htt) in both wild-type
and httQ140/Q140 culture systems. The level of Q22-htt expression was
approximately 1:1 with endogenous mhtt in httQ140/Q140 cultures
(Fig. 6A,B).
We next determined whether expression of wild-type htt could
rescue the activity-dependent defect in SV endocytosis in httQ140/Q140
striatal neurons. The expression of Q22-htt in wild-type striatal neurons
had no effect on the evoked syp-pH response (Fig. 6C,D), indicating that
overexpression of wild-type htt is not deleterious to SV endocytosis.
When Q22-htt was expressed in httQ140/Q140 striatal neurons, a full
restoration of kinetics to wild-type levels was observed (Fig. 6C,D).
Fig. 5. – SV exocytosis is unaffected in httQ140/Q140
neurons during high neuronal activity. Primary cultures
of either hippocampal (HPC) or striatal (STR) neu-
rons generated from either wild-type (WT) or
httQ140/Q140 (Q140) mice were transfected with sy-
naptophysin-pHluorin (syp-pH). (A) Q140 STR neu-
rons were challenged with a train of 400 electrical
field stimuli delivered at 40 Hz followed by a pulse of
ammonium chloride (NH4Cl) buffer in either the
presence (black trace) or absence (blue trace) of
1 μM bafilomycin A1 (Baf, which arrests SV acid-
ification after endocytosis). The time course of the
syp-pH response is displayed as a proportion of the
total SV recycling pool (revealed by NH4Cl) ± SEM
(Q140 - Baf n=6, Q140+Baf n=3). Bars indicate
period of stimulation or application of NH4Cl. (B,C)
Cultures were treated with 0.5 μM of htt hsiRNA
(KD) or a non-targeting control (NTC) for 7 days
previously. Cultures were challenged with a train of
400 electrical field stimuli delivered at 40 Hz fol-
lowed by a pulse of NH4Cl buffer. Bar graphs display
the extent of the syp-pH response in either HPC (B)
or STR (C) neurons as a proportion of the total SV
recycling pool (revealed by NH4Cl) ± SEM. Red
points indicate WT NTC neurons, maroon points WT
KD, blue points Q140 NTC and light blue Q140 KD
neurons. There was no significant difference in the
evoked peak height for any stimulation condition or
brain region (HPC WT n=7 NTC, n= 5 KD; HPC
Q140, n=5 NTC, n=6 KD: STR WT n=7 NTC,
n= 11 KD; STR Q140 n=4 NTC, n=5 KD, one-
way ANOVA, all ns). (For interpretation of the re-
ferences to colour in this figure legend, the reader is
referred to the web version of this article.)
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Thus, the activity-dependent defect in SV endocytosis in striatal httQ140/
Q140 neurons is fully rescued by expression of Q22-htt, confirming loss
of htt function as a key determinant in the perturbation of presynaptic
performance in this HD system.
3.5. Heterozygous httQ140/+ neurons display striatum-specific, activity-
dependent defects in SV endocytosis
We have revealed a striatum-specific and activity-dependent de-
fect in SV endocytosis in httQ140/Q140 neurons, which is due to a loss
of wild-type htt function. However, HD patients typically have only
one copy of the mutant htt allele (Tyebji and Hannan, 2017),
therefore it is important for disease relevance to determine whether
this defect also occurs in heterozygous httQ140/+ neurons. To in-
vestigate this, we challenged striatal httQ140/+ neurons with a train
of high frequency stimuli and monitored the syp-pH response. A
significant slowing of SV endocytosis was observed, with the time
constant of syp-pH fluorescence decay comparable to that of either
httQ140/Q140 neurons or wild-type neurons where htt had been de-
pleted via hsiRNA (Fig. 3C,D). Therefore, this striatum-specific ac-
tivity-dependent defect in SV endocytosis also occurs in the hetero-
zygous condition, suggesting it may have clinical relevance.
4. Discussion
We have identified a striatum-specific defect in SV endocytosis
that results from a loss of wild-type htt function in neurons derived
from a pre-symptomatic HD mouse model. This defect was only re-
vealed during intense neuronal activity, suggesting that loss of wild-
type htt function results in an inability of httQ140/Q140 neurons to
sustain their normal function during these conditions. This defect
was also observed in heterozygous neurons, suggesting it may have
disease relevance. Finally, we were able to rescue SV endocytosis in
striatal httQ140/Q140 neurons by introducing wild-type htt, con-
firming that this defect was a result of loss of wild-type htt function.
These results reveal that presynaptic dysfunction occurs before
clinical symptoms of HD manifest themselves and may be part of a
cascade of deleterious synaptic events that culminate in synapse loss
and degeneration of striatal neurons.
4.1. Choice of HD mouse model
A major rationale for our study was to identify presynaptic dis-
ease signatures at an age before any pathological, behavioral or
motor correlate of HD are known to be apparent. We therefore chose
the httQ140/Q140 knock-in mouse model for this study. This model
system expresses full-length mhtt at endogenous levels, and only
begins to display neuropathological abnormalities at 4 months and
gait anomalies at 1 year (Hickey et al., 2008; Menalled et al., 2003).
Therefore, we are confident that the activity-dependent defect in SV
endocytosis observed in httQ140/Q140 neurons represents early pre-
synaptic dysfunction that would precede HD symptoms. This con-
trasts with a number of other preclinical HD models, such as the R6/
2 mouse, which displays a considerably accelerated disease
Fig. 6. – Q22-htt expression rescues the activity-de-
pendent SV endocytosis defect in striatal httQ140/Q140
neurons. (A,B) Primary cultures from the hippo-
campus (HPC) of either wild-type (WT) or HttQ140/
Q140 (Q140) mice were transfected with synapto-
physin-pHluorin (syp-pH) and either empty
pcDNA3.1 vector (Emp) or Q22-htt (Q22 OE) 7 days
before fixation and immunostaining for both GFP
(syp-pH) and htt. (A) Representative images show
the syp-pH transfected neuron (arrow) and expres-
sion of htt. Scale bar indicates 20 μm. (B) Bar graph
shows quantification of the level of htt expression as
a percentage of untransfected neurons in the same
field of view. Red points indicate WT Emp neurons,
green points WT Q22, blue points Q140 Emp and
green Q140 Q22 neurons (WT Emp n=4, WT Q22
n=5, Q140 Emp n=9, Q140 Q22 n=7). Two-
tailed student's t-test *= p= .017 for WT and
***= p < .001 for Q140. (C,D) Primary striatal
(STR) cultures from WT or Q140 mice were trans-
fected with synaptophysin-pHluorin (syp-pH) and
either Q22-htt (Q22) or an empty pcDNA3.1 vector
(Emp). After 7 days cultures were stimulated with a
single train of 400 electrical field stimuli at 40 Hz
frequency. (C) Time course of the syp-pH response is
displayed for either WT or Q140 neurons expressing
either Emp or Q22-htt (ΔF/F0 ± SEM). Bar indicates
period of stimulation. Red traces WT Emp neurons,
green traces WT Q22, blue traces Q140 Emp and
black traces Q140 Q22 neurons (D) Quantification of
the time constant (τ) for the syp-pH fluorescence
decrease (WT Emp n=5, WT Q22 n=6; Q140 Emp
n=9, Q140 Q22 n=8 independent experiments,
*** p < .001 against Q140 empty, one-way
ANOVA). (For interpretation of the references to
colour in this figure legend, the reader is referred to
the web version of this article.)
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progression, making a delineation between pre-symptomatic and
symptomatic disease signatures more challenging. Such models
(which overexpress mhtt exon 1 containing a large CAG repeat)
display behavioral changes considerably earlier than full-length mhtt
knock-in models and die within 4 months (Mangiarini et al., 1996).
Moreover, nuclear inclusions appear in these models even before
these symptoms appear (Morton et al., 2000). The loss of function in
httQ140/Q140 neurons is not due to reduced presynaptic expression of
mhtt, since it is detected at equivalent levels to wild-type neurons in
these compartments (Valencia et al., 2013). Furthermore, no sig-
nificant change in the expression levels of a series of selected pre-
synaptic proteins was detected at 3 months (Valencia et al., 2013),
suggesting that global alterations in presynaptic protein expression
are not responsible for the defect in SV endocytosis identified in this
study.
4.2. Activity-dependent and striatum-specific defect in SV endocytosis in HD
neurons
We observe a selective vulnerability in SV endocytosis in striatal
httQ140/Q140 neurons only during intense neuronal activity. This is
likely to reflect slowing of clathrin-mediated endocytosis, since the
clathrin inhibitor pitstop-2 almost eliminated the syp-pH downstroke
after high frequency stimulation (Supplementary Fig. 4). It should
also be noted that these cultures are enriched for MSNs, but will
contain other neuronal subtypes. A slowing in the kinetics of the syp-
pH response could be due to ineffective SV acidification, rather than
retarded SV endocytosis (Watanabe et al., 2018). However, the ab-
sence of effect at low stimulation frequencies in striatal neurons and
during both stimulation protocols in hippocampal neurons does not
support this possibility. The molecular locus of this SV endocytosis
defect is still unknown, however htt binds to numerous proteins that
have direct roles in endocytosis, with polyglutamine expansion al-
tering many of these interactions (Borgonovo et al., 2013; El-Daher
et al., 2015; Engqvist-Goldstein et al., 2001; Li et al., 2008; Sittler
et al., 1998). One specific association is with the clathrin adaptor
protein AP-2, which is disrupted on poly-glutamine expansion, re-
sulting in a loss of function (Borgonovo et al., 2013). In agreement,
we have also demonstrated a reduced interaction of mhtt with AP-2
in synaptosomes derived from httQ140/Q140 mice (Supplementary
Fig. 5). Interestingly, AP-2 recruitment to the plasma membrane is
disrupted in the striatum of HD mice, but not the cortex, cerebellum
or hippocampus (Borgonovo et al., 2013). Therefore striatal httQ140/
Q140 neurons may operate normally during low frequency input,
however as the demand for SV endocytosis increases during elevated
activity, the impact of inefficient AP-2 recruitment via mhtt may
become apparent. Alternatively, the inability of httQ140/Q140 striatal
neurons to cope during intense neuronal activity may be a secondary
consequence of an as-yet unidentified presynaptic process that re-
tards SV endocytosis. In this scenario, most neurons are able to adapt
their presynaptic function to compensate for the absence of this
particular process during intense activity, however an intrinsic de-
fect within httQ140/Q140 striatal neurons may render them specifically
vulnerable. The identity of such a molecular or process deficit is
currently unknown, however should be revealed through a sys-
tematic interrogation of the role of wild-type htt in presynaptic
function.
A recent study revealed that presynaptic dysfunction occurred in
an in vitro cortico-striatal co-culture system using httQ140/+ mice
(Virlogeux et al., 2018). In this system, httQ140/+ cortical neurons
displayed a decrease in the number of nerve terminals releasing
glutamate regardless of their co-cultured synaptic partner (httQ140/+
or wild-type striatal neurons). Unfortunately, is it difficult to relate
our work to this study for a number of reasons. These are; 1) SV
recycling was not monitored in either cortical or striatal neurons; 2)
cortical neurons were stimulated using a prolonged (5 min) exposure
to inhibitory receptor antagonists (rather than brief trains of phy-
siologically-relevant field stimuli); 3) the frequency of stimulation
could not be modulated (due to the chemical depolarization) and 4)
glutamate release was recorded using the genetically-encoded re-
porter GluSNFr (Marvin et al., 2013), the output from which was
thresholded to produce a binary outcome – an active or non-active
synapse. When one considers that the number of nerve terminals was
reduced to a similar extent in cultures containing cortical httQ140/+
neurons, this suggests that the observed potential dysfunction was
simply a result of less cortical synapses in the co-culture system.
4.3. Activity-dependent SV endocytosis defect in striatal HD neurons is due
to htt loss of function
Individuals with HD are heterozygous for the mhtt allele, in-
dicating a dominant pattern of inheritance. We observe a conserva-
tion of the activity-dependent SV endocytosis defect in striatal
httQ140/+ neurons, highlighting a potential relevance for disease
progression. The loss of function phenotype we observe suggests that
it may result from htt haploinsufficiency. In support, heterozygous
htt knockout mice display a series of cognitive, motor and patholo-
gical alterations that are comparable to those observed in knock-in
models of HD (Menalled et al., 2009; Nasir et al., 1995; O'Kusky
et al., 1999). Furthermore, conditional knockout of wild-type htt in
adult brain forebrain results in extensive degeneration of a number
of different neuronal subtypes, motor phenotypes and early mortality
(Dragatsis et al., 2000). Alternatively, mhtt may still act in a domi-
nant negative manner in heterozygotes to ablate wild-type htt
function. In support, selective silencing of the mhtt allele was suffi-
cient to restore normal brain-derived neurotrophic factor transport
in HD patient cells (Drouet et al., 2014). Our observation that ex-
pression of wild-type htt fully rescues presynaptic function in
httQ140/Q140 neurons argues against this, however it should be borne
in mind that the expression levels of both wild-type htt and mhtt are
approximately double when compared to the heterozygous condition
in HD.
There has been considerable investment over the past decade in
the development of a series of htt-lowering therapies (Caron et al.,
2018). The logic of this approach is that the majority of deleterious
effects observed are associated with a toxic gain of htt function. Our
work, and that of others (Gauthier et al., 2004), reveal that loss of
wild-type htt function also causes neuronal dysfunction and this
should be considered in htt-lowering strategies. It also reveals that
there is a relatively tight therapeutic window, since a reduction in
wild-type htt expression from approximately 100% (in corrected
httQ140/Q140 neurons, Fig. 6B) to 50% (in httQ140/+ neurons) results
in presynaptic dysfunction.
Typically, slowed SV endocytosis results in a decrease in neuro-
transmission, which is due to a short-term depletion in SV numbers
(Chen et al., 2003; Koh et al., 2004; Koo et al., 2015; Shupliakov
et al., 1997). How might this alteration in SV endocytosis translate
into altered striatal output in HD? MSNs have two specific outputs,
the direct (projecting to the substantia nigra pars reticulata) or in-
direct (projecting to the external globus pallidus) pathway (Cepeda
et al., 2014; Galvan et al., 2012; Rangel-Barajas and Rebec, 2016).
MSNs of the indirect pathway appear to be particularly vulnerable in
HD, which is proposed to lead to the observed chorea (Albin et al.,
1992; Reiner et al., 1988). In addition, comparative studies of the
two pathways suggest that MSNs of the indirect pathway fire at
higher frequencies when injected with the same current as direct
pathway MSNs (Gertler et al., 2008; Kreitzer and Malenka, 2007).
The disproportionate excitability of these GABAergic MSNs may
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therefore result in decreased inhibitory drive though the indirect
pathway, due to slowed SV endocytosis. Recent studies indicate that
activation of indirect MSNs resulted in increased responses of direct
pathway MSNs in HD mouse models (Barry et al., 2018), suggesting
dysfunctional SV retrieval may contribute towards this increased
communication. Directly addressing this hypothesis will be challen-
ging, however the advent of new genetic and optogentic tools to
dissect these pathways (Barry et al., 2018; Galvan et al., 2012) may
provide a potential future research avenue.
5. Conclusions
The genetic cause and the progression of HD have been known for
20 years (Tyebji and Hannan, 2017; Zuccato and Cattaneo, 2014).
However, the key molecular events that precipitate the degeneration
of striatal MSNs and movement disorders remain unclear. An emer-
ging view is that an intrinsic susceptibility of specific subtypes of
neurons may render them progressively vulnerable to repeated insult
or stressors, culminating in synapse failure and degeneration in later
life. Repeated patterns of high frequency input may be such a phy-
siological insult, rendering neurons that encounter such input at risk
of dysfunctional neurotransmitter release and ultimately synaptic
failure. The identification of key activity-dependent disease sig-
natures in striatal neurons that occur before the manifestation of
clinical symptoms is a promising avenue for future therapeutic in-
tervention, since their early correction may ameliorate future sy-
naptic loss and degeneration.
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